35 related articles for article (PubMed ID: 8748421)
21. A comparison and critique of historical and current exposure assessment methods for beryllium: implications for evaluating risk of chronic beryllium disease.
Kolanz ME; Madl AK; Kelsh MA; Kent MS; Kalmes RM; Paustenbach DJ
Appl Occup Environ Hyg; 2001 May; 16(5):593-614. PubMed ID: 11370938
[TBL] [Abstract][Full Text] [Related]
22. [Beryllium--underestimated occupational health hazard in Poland].
Dudek W; Walusiak J; Wittczak T
Med Pr; 2001; 52(6):471-8. PubMed ID: 11928678
[TBL] [Abstract][Full Text] [Related]
23. Advances in identifying beryllium sensitization and disease.
Middleton D; Kowalski P
Int J Environ Res Public Health; 2010 Jan; 7(1):115-24. PubMed ID: 20195436
[TBL] [Abstract][Full Text] [Related]
24. Sarcoidosis and chronic beryllium disease: similarities and differences.
Mayer AS; Hamzeh N; Maier LA
Semin Respir Crit Care Med; 2014 Jun; 35(3):316-29. PubMed ID: 25007084
[TBL] [Abstract][Full Text] [Related]
25. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease.
Balmes JR; Abraham JL; Dweik RA; Fireman E; Fontenot AP; Maier LA; Muller-Quernheim J; Ostiguy G; Pepper LD; Saltini C; Schuler CR; Takaro TK; Wambach PF;
Am J Respir Crit Care Med; 2014 Nov; 190(10):e34-59. PubMed ID: 25398119
[TBL] [Abstract][Full Text] [Related]
26. Beryllium in the environment: a review.
Taylor TP; Ding M; Ehler DS; Foreman TM; Kaszuba JP; Sauer NN
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2003 Feb; 38(2):439-69. PubMed ID: 12638707
[TBL] [Abstract][Full Text] [Related]
27. Clinical application of beryllium lymphocyte proliferation testing.
Barna BP; Culver DA; Yen-Lieberman B; Dweik RA; Thomassen MJ
Clin Diagn Lab Immunol; 2003 Nov; 10(6):990-4. PubMed ID: 14607857
[No Abstract] [Full Text] [Related]
28. [Immunotoxicity of beryllium].
Sakaguchi T; Sakaguchi S; Kudo Y
Nihon Eiseigaku Zasshi; 1998 Jan; 52(4):611-7. PubMed ID: 9528258
[TBL] [Abstract][Full Text] [Related]
29. Off the Beaten Track-A Hitchhiker's Guide to Beryllium Chemistry.
Naglav D; Buchner MR; Bendt G; Kraus F; Schulz S
Angew Chem Int Ed Engl; 2016 Aug; 55(36):10562-76. PubMed ID: 27364901
[TBL] [Abstract][Full Text] [Related]
30. Application of beryllium antibodies in risk assessment and health surveillance: two case studies.
Clarke SM; Thurlow SM; Hilmas DE
Toxicol Ind Health; 1995; 11(4):399-411. PubMed ID: 8748421
[TBL] [Abstract][Full Text] [Related]
31. Introduction to beryllium: uses, regulatory history, and disease.
Kolanz ME
Appl Occup Environ Hyg; 2001 May; 16(5):559-67. PubMed ID: 11370935
[TBL] [Abstract][Full Text] [Related]
32. Beryllium: a modern industrial hazard.
Kreiss K; Day GA; Schuler CR
Annu Rev Public Health; 2007; 28():259-77. PubMed ID: 17094767
[TBL] [Abstract][Full Text] [Related]
33. Systematic review: Progression of beryllium sensitization to chronic beryllium disease.
Seidler A; Euler U; Müller-Quernheim J; Gaede KI; Latza U; Groneberg D; Letzel S
Occup Med (Lond); 2012 Oct; 62(7):506-13. PubMed ID: 22705916
[TBL] [Abstract][Full Text] [Related]
34. Chronic Beryllium Disease: Update on a Moving Target.
MacMurdo MG; Mroz MM; Culver DA; Dweik RA; Maier LA
Chest; 2020 Dec; 158(6):2458-2466. PubMed ID: 32768458
[TBL] [Abstract][Full Text] [Related]
35. Beryllium exposure: dermal and immunological considerations.
Day GA; Stefaniak AB; Weston A; Tinkle SS
Int Arch Occup Environ Health; 2006 Feb; 79(2):161-4. PubMed ID: 16231190
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
